The Charlotte, N.C.-based health system is joining the voluntary MDIAS collaboration between the U.S. FDA and stakeholders across the private sector—including patients, hospital providers, and medical device manufacturers—to proactively analyze medical-device-related data to improve healthcare outcomes for consumers.
“It’s a pleasure to welcome Atrium Health to MDIAS,” says Kim Warren, vice president of Mitre’s Center for Transforming Health, operator of the CMS Alliance to Modernize Healthcare, a federally funded research and development center more commonly known as the Health FFRDC. “As an early adopter—and the very first health system to join MDIAS—Atrium Health’s active participation will benefit patients, regulators, and the medical device ecosystem.”
MDIAS convenes multiple stakeholders to discuss medical device quality and safety issues and solve those challenges collaboratively. Participants agree to share appropriate data with Mitre for analysis and development of recommendations for organizational and industry-wide performance improvement.
“Safety is at the heart of our organization,” says Rasu Shrestha, MD, MBA, executive vice president and chief innovation and commercialization officer for Advocate Health, of which Atrium Health is a part.
“Delivering the safest care and highest-quality outcomes ensures we are the most trusted choice for care,” Shrestha adds. “We’re also driven to advance the science of medicine in the most innovative ways possible. To that end, our team is dedicated to developing the most comprehensive provider-based research data set in the country. Our organization is excited for this opportunity to join MDIAS to help improve patient safety across the entire healthcare industry.”